Prostaglandins Involving in Blastocyst Development through Calcium Mediated Signaling Pathway

  • Lee, Ja-Myong (School of Biosciences and Chemistry, Center for NanoBio Applied Technology, Institute of Basic Sciences, Sungshin Women's University) ;
  • Kwon, Hyuck-Chan (MiraewaHeeMang Hospital) ;
  • Lee, Seung-Jea (MiraewaHeeMang Hospital) ;
  • Cheon, Yong-Pil (School of Biosciences and Chemistry, Center for NanoBio Applied Technology, Institute of Basic Sciences, Sungshin Women's University)
  • 투고 : 2011.01.15
  • 심사 : 2011.03.07
  • 발행 : 2011.03.31

초록

Lipid metabolites involved in cellular regulation as signaling mediators. Prostaglandins (PGs), metabolites of lipid are involved to pregnancy at the time of implantation but the functional roles of PGs on embryo development are still controversy and largely unknown. In previous report, the levels of $PGE_2$ and $PGF_{2a}$ at embryos of morula stage and blastocyst stage were explored (Cheon et al., 1998). In this study, the previous suggestion was confirmed and the possible downstream mediator of prostaglandin $E_2$ and prostaglandin $F_{2a}$ on the expansion and hatching of mouse embryo was examined. As expected, developmental rate of the blastocyst to expanded stage was a concentration-response curve that showed the highest expansion rate at 10 ${\mu}M$ $PGE_2$, but at 100 ${\mu}M$ $PGE_2$, the rate was decreased. In contrast to the $PGE_2$, $PGF_{2a}$ stimulated expansion without toxicity at highest concentration. Cotreatment of PGs with indomethacin overcame the inhibitory effects of indomethacin in expansion. Exogenous PGs also improved the development of expanded embryos to the hatching stage. Besides, PGs receptors' transcripts detected at blastocyst. $PGE_2$ was caused of calcium fluctuation in the blastocyst but $PGF_{2a}$ did not. The changes of intracellular calcium concentration were different between indomethacin pretreated embryos and non-treated embryos. Based on these results it is suggested that PGs work as paracrine and/or autocrine factors through calcium and the others which were not identified in this study.

키워드

참고문헌

  1. Arvisais E, Hou X, Wyatt TA, Shirasuna K, Bollwein H, Miyamoto A, Hansen TR, Rueda BR, Davis JS (2010) Prostaglandin F2alpha represses IGF-1-stimulated IRS1/phosphatidylinositol-3-kinase/AKT signaling in the corpus luteum: role of ERK and P70 ribosomal S6 kinase. Mol Endocrinol 24:632-643. https://doi.org/10.1210/me.2009-0312
  2. Audoly LP, Tillery SL, Goulet J, Key M, Nguyen M, Stock JL, McNeish JD, Koller BH, Coffman TM (1999) Identification of specific EP receptors responsible for the hemodynamic effects of $PGE_2$. Am J Physiol 277:H924-H930.
  3. Campbell W, Halushka P (1996) The pharmacological basis of therapeutics. In: Goodman & Gilman9s, Hardman, J. & Limbird, eds. McGraw-Hill, New York, pp. 601-616.
  4. Cha YI, Solnica-Krezel L, DuBois RN (2006) Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. Dev Biol 289:263-272. https://doi.org/10.1016/j.ydbio.2005.10.013
  5. Cheon YP (2005) Concanavalin A mediated calcium changes on expansion and hatching of the mouse blastocyst. Kor J Fertil Steril 32:337-346.
  6. Cheon YP, Gye MC, Kim CH, Kim MK (1997) Effects of indomethacin on development and hatching of mouse embryo. Kor J Fertil Steril 24:35-42.
  7. Cheon YP, Kim CH, Yoon YD, Kim MK (1998) Effects of prostaglandins on embryonic expansion and hatching by developmental stage in mouse. Dev Reprod 2:179-187.
  8. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM, Gorry SA, Trzaskos JM (1995) Renal abnormalities and an altered inflammatory response in mice lacking cyclooxytenase II. Nature 378:406-409. https://doi.org/10.1038/378406a0
  9. Gemzell-Danielsson K, Hamberg M (1994) The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin $F_2$ alpha concentrations. Hum Reprod 9:1626-1630. https://doi.org/10.1093/oxfordjournals.humrep.a138763
  10. Griffin BW, Williams GW, Crider JY, Sharif NA (1997) FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study. J Pharmacol Exp Ther 281:845-854.
  11. Hatae N, Sugimoto Y, Ichikawa A (2002) Prostaglandin receptors: advances in the study of EP3 receptor signaling. J Biochem 131:781-784. https://doi.org/10.1093/oxfordjournals.jbchem.a003165
  12. Helliwell RJ, Bery EB, O'Carroll SJ, Mitchell MD (2004) Nuclear prostaglandin receptors role in pregnancy and parturition? Prostaglandins Leukot Essent Fatty Acids 70:149-165. https://doi.org/10.1016/j.plefa.2003.04.005
  13. Huang JC, Wun WSA, Goldsby Js, Matijevic-Aleksic N, Wu KK (2004) Cycloocygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching. Hum Reprod 19:2900-2906. https://doi.org/10.1093/humrep/deh524
  14. Johnson DC, Dey SK (1980) Role of histamine in implantation: dexamethasone inhibits estradiol-induced implantation in the rat. Biol Reprod 22:1136-1141.
  15. Kennedy TG (1979) Prostaglandins and increased endometrial vascular permeability resulting from the application of an artificial stimulus to the rat sensitized for the decidual cell reaction. Biol Reprod 20:560-566. https://doi.org/10.1095/biolreprod20.3.560
  16. Kennedy TG, Armstrong DT (1981) The role of prostaglandins in endometrial vascular changes at implantation. In: Glasser SR and Bullock DW, Cellular and Molecular Aspects of Implantation. Plenum Press, New York, pp. 349-358.
  17. Kennedy CR, Zhang Y, Brandon S, Guan Y, Coffee K, Funk CD, Magnuson MA, Oates JA, Breyer MD, Breyer RM (1999) Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin $EP_2$ receptor. Nat Med 5:217-220. https://doi.org/10.1038/5583
  18. Konger RL, Billings SD, Thompson AB, Morimiya A, Ladenson JH, Landt Y, Pentland AP, Badve S (2005) Immunolocalization of low-affinity prostaglandin $E_2$ receptors, $EP_1$ and $EP_2$, in adult human epidermis. J Investi Dermatol 124:965-970. https://doi.org/10.1111/j.0022-202X.2005.23658.x
  19. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, lee CA, Goulding EH, Kluckman KD, Kim HS, Smithies O (1995) Pro-Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacininduced gastic ulceration. Cell 83:483-492. https://doi.org/10.1016/0092-8674(95)90126-4
  20. Marnett LJ, DuBois RN (2002) COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol 42:55-80. https://doi.org/10.1146/annurev.pharmtox.42.082301.164620
  21. Nguyen M, Camenisch T, Snouwaert JN, Hicks E, Coffman TM. Anderson PA, Malouf NN, Koller BH (1997) The prostaglandin receptor $EP_4$ triggers remodeling of the cardiovascular system at birth. Nature 390:78-81. https://doi.org/10.1038/36342
  22. Nirodi CS, Crews BC, Kozak KR, Morrow JD, Marnett LJ (2004) The glyceryl ester of prostaglandin $E_2$ mobilizes calcium and activates signal transduction in RAW264.7 cells. Proc Natl Acad Sci USA 101:1840-1845. https://doi.org/10.1073/pnas.0303950101
  23. Niimura S, Ishida K (1987) Immunohistochemical demonstration of prostaglandin $E_2$ in preimplantation mouse embryos. J Reprod Fertil 80:505-508. https://doi.org/10.1530/jrf.0.0800505
  24. Pakrasi PL, Jain AK (2008) Cyclooxygenase-2-derived endogenous prostacyclin redues apoptosis and enhances embryo viability in mouse. Prostaglandins Leukot Essent Fatty Acids 79:27-33. https://doi.org/10.1016/j.plefa.2008.07.006
  25. Robertson SA, Christiaens I, Dorian CL, Zaragoza DB, Care AS. Banks AM, Olson DM (2010) Interleukin-6 is an essential determinant of on-time parturition in the mouse. Endocrinology 151:3996-4006. https://doi.org/10.1210/en.2010-0063
  26. Smith OP, Jabbour HB, Critchley HO (2007) Cyclooxygenase enzyme expression nad E series prostaglandin receptor signaling are enhanced in heavy menstruation. Hum Reprod 22:1450-1456. https://doi.org/10.1093/humrep/del503
  27. Snabes MC, Harper MJK (1984) Site of action of imdomethacin on implantation in the rabbi. J Reprod Fertil 71:559-565. https://doi.org/10.1530/jrf.0.0710559
  28. Srinivasan D, Fujino H, Regan JW (2002) Differential internalization of the prostaglandin F(2alpha) receptor isoforms: role of protein kinase C and clathrin. J Parmacol Exp Ther 302:219-224. https://doi.org/10.1124/jpet.302.1.219
  29. Stachecki JJ, Yelian FD, Schultz JF, Leach RE, Armant DR (1994) Blastocyst caviation is accelerated by ethanol- or ionophore-induced elevation o intracellular calcium. Biol Reprod 50:1-9. https://doi.org/10.1095/biolreprod50.1.1
  30. Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T, Oida H, Yoshida N, Tanaka T, katsuyama M, Hasumoto K, Murata T, Hirata M, Ushikubi F, negishi M, Ichikawa A, Narumiya S (1997) Failure of parturition in mice lacking the prostaglandin F receptor. Science 277:681-683. https://doi.org/10.1126/science.277.5326.681
  31. Takami T, Sakamoto H, Takami M, Hayakawa S, Satoh K (1994) Cyclooxygenase in ooplasm is essential for early embryonal differentiation but not for successful fertilization in the mouse. Nippon Sanka Fujinka Gakkai Zasshi 46:295-300.
  32. Tan HN, Liu Y, Diao HL, Yang ZM (2005) Cyclooxygenases and prostaglandin E synthases in preimplantation mouse embryos. Zygote 13:103-108. https://doi.org/10.1017/S0967199405003187
  33. van der Weiden RM, Wisse LJ, Helmerhorst FM, Keirse MJ, Poelmann RE (1996) Immunohistochemical and ultrastructural localization of prostaglandin H synthase in the preimplantation mouse embryo. J Reprod Fertil 107:161-166. https://doi.org/10.1530/jrf.0.1070161
  34. Weber JA, Freeman DA, Vanderwall DK, Wods GL (1991) Prostaglandin $E_2$ secretion by oviductal transport-stage equine embryos. Biol Reprod 45:540-543. https://doi.org/10.1095/biolreprod45.4.540
  35. Zhu T, Gobeil F, Vazquez-Tello A, Leduc M, Rihakova L, Bossolasco M, Bkaily G, Peri K, Varma DR, Orvoine R, Cjemtob S (2006) Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors a paradigm based on $PGE_2$, PAF, and LPA1 receptors. Can J Physiol Pharmacol 84:377-391. https://doi.org/10.1139/y05-147